• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人腺病毒载体对一种酶编码基因在小鼠体内的转移和表达进行评估。

Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector.

作者信息

Stratford-Perricaudet L D, Levrero M, Chasse J F, Perricaudet M, Briand P

机构信息

Laboratoire de Génétique des Virus Oncogènes, Institut Gustave-Roussy, Villejuif, France.

出版信息

Hum Gene Ther. 1990 Fall;1(3):241-56. doi: 10.1089/hum.1990.1.3-241.

DOI:10.1089/hum.1990.1.3-241
PMID:2081192
Abstract

Mutant mice of the Spf-ash strain have an inherited defect in ornithine transcarbamylase (OTC) protein synthesis, and were used to ascertain the potential of recombinant adenoviruses for introducing and expressing the normal gene lacking in these mice. These OTC mutant mice are characterized by a reduction in the amount of OTC activity, resulting in hyperammonemia, pronounced orotic aciduria, growth retardation, and sparse fur until weaning. A recombinant adenovirus that harbors the rat OTC cDNA under the control of the viral major late promoter (MLP) was constructed and injected into such newborn mice. The effect of the virus was analyzed by monitoring the hepatic OTC enzyme during several months after the injection. An increase in OTC activity was detected and was accompanied by a diminution of orotic acid in the urine. The observation of MLP-OTC mRNA transcripts over 1 year following the injection attests to the relatively long-term presence of the transferred gene. In those mice showing the greatest OTC activity, a normalization of the fur was also observed. The experiments reported here document the feasibility of using adenovirus for the direct delivery in vivo of a gene to restore an impaired metabolism.

摘要

Spf-ash品系的突变小鼠在鸟氨酸转氨甲酰酶(OTC)蛋白合成方面存在遗传性缺陷,被用于确定重组腺病毒导入并表达这些小鼠所缺乏的正常基因的潜力。这些OTC突变小鼠的特征是OTC活性降低,导致高氨血症、明显的乳清酸尿、生长迟缓以及断奶前毛发稀疏。构建了一种在病毒主要晚期启动子(MLP)控制下携带大鼠OTC cDNA的重组腺病毒,并将其注射到此类新生小鼠体内。通过在注射后的几个月内监测肝脏OTC酶来分析病毒的作用。检测到OTC活性增加,同时尿液中乳清酸减少。注射后1年多对MLP-OTC mRNA转录本的观察证明了转移基因的相对长期存在。在那些显示出最高OTC活性的小鼠中,还观察到毛发恢复正常。此处报道的实验证明了使用腺病毒在体内直接递送基因以恢复受损代谢的可行性。

相似文献

1
Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector.利用人腺病毒载体对一种酶编码基因在小鼠体内的转移和表达进行评估。
Hum Gene Ther. 1990 Fall;1(3):241-56. doi: 10.1089/hum.1990.1.3-241.
2
Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.利用携带CAG启动子的重组腺病毒纠正成年无特定病原体(灰)小鼠和鸟氨酸转氨甲酰酶缺陷型人肝细胞中的鸟氨酸转氨甲酰酶缺乏症。
Hum Gene Ther. 1996 May 1;7(7):821-30. doi: 10.1089/hum.1996.7.7-821.
3
Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.新合成的鸟氨酸转氨甲酰酶(OTC)的高效线粒体导入以及在对OTC缺乏症进行基因治疗后spf(ash)小鼠继发性代谢改变的纠正。
Mol Med. 1999 Apr;5(4):244-53.
4
Retroviral-mediated gene transfer of human ornithine transcarbamylase into primary hepatocytes of spf and spf-ash mice.逆转录病毒介导的人鸟氨酸转氨甲酰酶基因转移至无特定病原体(SPF)和无特定病原体-无鼠肝炎病毒(SPF-ASH)小鼠的原代肝细胞中。
Hum Gene Ther. 1992 Feb;3(1):35-44. doi: 10.1089/hum.1992.3.1-35.
5
Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.通过基因转移到生殖系来纠正小鼠鸟氨酸转氨甲酰酶缺乏症。
Nucleic Acids Res. 1988 Mar 25;16(5):2099-110. doi: 10.1093/nar/16.5.2099.
6
Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene.通过导入大鼠鸟氨酸转氨甲酰酶(OTC)基因使稀疏皮毛-异常皮肤和毛发(SPF-ASH)小鼠的毛发生长正常化。
J Dermatol Sci. 1994 Jul;7 Suppl:S27-32. doi: 10.1016/0923-1811(94)90032-9.
7
Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.用腺相关病毒载体进行肝脏定向治疗后,鸟氨酸转氨甲酰酶缺陷小鼠氨代谢的长期纠正及生存期延长
Mol Ther. 2006 Jul;14(1):25-33. doi: 10.1016/j.ymthe.2006.03.009. Epub 2006 May 3.
8
AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia.新生无特定病原体(SPF)小鼠脑内递送 AAV 编码的 OTC 活性可持续至成年期,但不足以预防 shRNA 诱导的高血氨症。
Gene Ther. 2013 Dec;20(12):1184-7. doi: 10.1038/gt.2013.51. Epub 2013 Oct 10.
9
Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene.小肠中鸟氨酸转氨甲酰酶(OTC)缺乏对尿乳清酸排泄的重要性:对携带OTC转基因的OTC缺陷型spf-ash小鼠的分析。
Biochim Biophys Acta. 1995 Jan 25;1270(1):87-93. doi: 10.1016/0925-4439(94)00007-d.
10
Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.开发用于鸟氨酸转氨甲酰酶缺乏症的腺病毒介导的体内基因疗法。
J Inherit Metab Dis. 1998;21 Suppl 1:119-37. doi: 10.1023/a:1005369926784.

引用本文的文献

1
The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy.基因治疗的兑现承诺:肝脏定向基因治疗的过去、现在与未来
Mol Ther. 2025 May 7;33(5):1966-1987. doi: 10.1016/j.ymthe.2025.03.041. Epub 2025 Mar 27.
2
Gene therapy then and now: A look back at changes in the field over the past 25 years.彼时与此时的基因疗法:回顾过去25年该领域的变化。
Mol Ther. 2025 May 7;33(5):1889-1902. doi: 10.1016/j.ymthe.2025.02.040. Epub 2025 Feb 28.
3
An Analysis of Mechanisms for Cellular Uptake of miRNAs to Enhance Drug Delivery and Efficacy in Cancer Chemoresistance.
miRNA细胞摄取机制分析以增强癌症化疗耐药性中的药物递送及疗效
Noncoding RNA. 2021 Apr 16;7(2):27. doi: 10.3390/ncrna7020027.
4
Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.用外科用海绵配制的二价前列腺癌疫苗在前列腺特异性抗原转基因小鼠中引发抗原特异性效应T细胞。
Vaccine. 2017 Oct 13;35(43):5794-5798. doi: 10.1016/j.vaccine.2017.09.037. Epub 2017 Sep 20.
5
Cancer immunotherapy: a paradigm shift for prostate cancer treatment.癌症免疫疗法:前列腺癌治疗的范式转变。
Nat Rev Urol. 2012 May 29;9(7):376-85. doi: 10.1038/nrurol.2012.106.
6
Constitutive expression of short hairpin RNA in vivo triggers buildup of mature hairpin molecules.体内短发夹 RNA 的组成性表达引发成熟发夹分子的积累。
Hum Gene Ther. 2011 Dec;22(12):1483-97. doi: 10.1089/hum.2010.234. Epub 2011 Oct 4.
7
Perinatal gene transfer to the liver.围产期肝脏基因转移。
Curr Pharm Des. 2011;17(24):2528-41. doi: 10.2174/138161211797247541.
8
The influence of innate and pre-existing immunity on adenovirus therapy.先天免疫和固有免疫对腺病毒治疗的影响。
J Cell Biochem. 2009 Nov 1;108(4):778-90. doi: 10.1002/jcb.22328.
9
Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses.腺相关病毒介导的基因转移至非人灵长类动物肝脏可引发具有破坏性的转基因特异性T细胞反应。
Hum Gene Ther. 2009 Sep;20(9):930-42. doi: 10.1089/hum.2009.060.
10
Adenovirus-mediated gene delivery rescues a neonatal lethal murine model of mut(0) methylmalonic acidemia.腺病毒介导的基因传递挽救了mut(0)甲基丙二酸血症的新生儿致死性小鼠模型。
Hum Gene Ther. 2008 Jan;19(1):53-60. doi: 10.1089/hum.2007.0118.